<bill session="116" type="h" number="2734" updated="2022-02-08T23:19:26Z">
  <state datetime="2019-05-14">REFERRED</state>
  <status>
    <introduced datetime="2019-05-14"/>
  </status>
  <introduced datetime="2019-05-14"/>
  <titles>
    <title type="display">Safer Prescribing of Controlled Substances Act</title>
    <title type="official" as="introduced">To require certain practitioners authorized to prescribe controlled substances to complete continuing education.</title>
    <title type="short" as="introduced">Safer Prescribing of Controlled Substances Act</title>
  </titles>
  <sponsor bioguide_id="T000482"/>
  <cosponsors>
    <cosponsor bioguide_id="C001067" joined="2019-06-10"/>
    <cosponsor bioguide_id="H001081" joined="2019-12-04"/>
    <cosponsor bioguide_id="J000126" joined="2019-06-06"/>
    <cosponsor bioguide_id="L000591" joined="2019-10-23"/>
    <cosponsor bioguide_id="S001205" joined="2019-09-17"/>
    <cosponsor bioguide_id="S001209" joined="2019-12-04"/>
    <cosponsor bioguide_id="T000469" joined="2019-06-13"/>
    <cosponsor bioguide_id="T000483" joined="2019-07-30"/>
  </cosponsors>
  <actions>
    <action datetime="2019-05-14">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-05-14" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-05-14">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-05-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-06-26">
      <text>Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="1448" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Government information and archives"/>
    <term name="Health information and medical records"/>
    <term name="Health personnel"/>
    <term name="Medical education"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2020-07-21T10:55:58Z" status="Introduced in House">Safer Prescribing of Controlled Substances Act This bill establishes a new registration requirement for a practitioner (other than a hospital, pharmacy, or veterinarian) who is licensed to dispense or conduct research with a controlled substance in schedules II, III, IV, or V of the Controlled Substances Act.

Specifically, the practitioner must comply with a training requirement as a condition of obtaining or renewing their registration. The training must include information on best practices for pain management and responsible prescribing of pain medications.</summary>
</bill>
